Navigation Links
Pulmonary in Biological Technology

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... in patients that are at high risk for developing pulmonary embolism, which can be a life threatening ... to flow normally. Patients at high risk for pulmonary embolism are typically patients undergoing a ... studies to significantly reduce the risk of pulmonary embolism and related mortality in certain high ...

Next Safety Releases Advanced Respirator for Infectious Diseases

... the development, design and rapid production of pulmonary products like its 9000 series respirators. Next ... Next Safety is a leader in the development of pulmonary health products. It has a product line of ... applications. The company also develops pulmonary drug delivery products. It is a leader in the ...

New Report Just Published: World Endoscopy Systems Market Report

... III-6 Table 23: Leading Players in the US pulmonary Endoscopes Market (2008E): Percentage Share ... Breakdown of Dollar Sales for GI Endoscopes, pulmonary Endoscopes, Urology Endoscopes, Gynaecology ... III-31 Table 44: Leading Players in European pulmonary Endoscopes Market (2008E): Percentage ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... Dipropionate on Early Non-Infectious pulmonary Outcomes after Allogeneic Hematopoietic Cell ... treated with placebo developed non-infectious pulmonary complications, such as idiopathic pneumonia ... the Fred Hutchinson Cancer Research Center, where pulmonary function testing is done prospectively and all ...

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

... Filter is used for the prevention of recurrent pulmonary embolism (PE). The device is implanted, typically ... filter in patients at increased risk for pulmonary embolism. In the trial, clinical success, defined ... and can be used in the following conditions: pulmonary thromboembolism when anticoagulant therapy is ...

Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis

... of Oncothyreon's PX-866 in a preclinical model of pulmonary fibrosis. The data were presented earlier today by William D. Hardie, M.D., Associate Professor, pulmonary Medicine, Children's Hospital Medical Center, ... in such human lung diseases as idiopathic pulmonary fibrosis." "Although our current development ...

Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

... SAN FRANCISCO, Calif., May 18 /PRNewswire/ -- The pulmonary Hypertension Association (PHA), Tufts Medical ... recipient of the 2009 PHA Award of Excellence in pulmonary Arterial Hypertension (PAH) Care. The grant, in ... excellence in the area of PAH. "The pulmonary Hypertension Association Award of Excellence ...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

... of mortality in patients with idiopathic pulmonary fibrosis (IPF) will be presented in a poster ... OF MORTALITY IN PATIENTS WITH IDIOPATHIC pulmonary FIBROSIS (IPF) POSTER 216: P.W. Noble: ... PIRFENIDONE (PFD) IN PATIENTS WITH IDIOPATHIC pulmonary FIBROSIS (IPF) TUESDAY, MAY 19 ...

Pulmo BioTech Inc. Announces Paper to be Presented at Symposium

... Analogs Designed for Molecular Imaging of the pulmonary Circulation", will be part of the session "From a ... Molecular Imaging technique for the diagnosis of pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ...

CryoLife Reports Record First Quarter Revenues of $26.7 Million

... primarily from the Company's standard processed pulmonary valves. Revenues from the distribution of CryoValve(R) SG pulmonary heart valves increased to $1.2 million in the ... received FDA clearance for the CryoValve(R) SG pulmonary heart valve, processed using CryoLife's ...

Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman

... Safety, Inc. has developed the most effective pulmonary nicotine delivery device to help people quit ... Platform, the device was highly effective in the pulmonary delivery of nicotine and other drugs. The phase I ... platform is a powerful new method for the pulmonary delivery of drugs; the small handheld device will ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... organ creating a life-threatening condition - pulmonary embolism, or PE - which requires immediate ... 300,000 Americans die each year from pulmonary embolism (PE)(2), the majority of which result ... organ creating a life-threatening condition - pulmonary embolism, or PE - which requires immediate ...

Savara Expands Board of Directors, Appoints Three New Members

... Nevan Elam, Former Head of Nektar Therapeutic's pulmonary Business Unit, Among New Board of Directors ... new members. Nevan Elam, former head of the pulmonary business unit at Nektar Therapeutics, has been ... including Mr. Elam's proven track record in the pulmonary drug delivery space, will provide an essential ...

InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights

... 3 CAPACITY program for pirfenidone in idiopathic pulmonary fibrosis (IPF) and are now preparing the New Drug ... has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) ... a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes ...

Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results

... completed the divestiture of certain of its pulmonary delivery assets to Novartis for $115.0 million on ... activities: Gain on sale of pulmonary assets (69,572) - ... investing activities: Proceeds from sale of pulmonary assets, net of transactions cost ...

CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008

... tissues, the introduction of the CryoValve(R) SG pulmonary human heart valve processed with the ... Revenues from the distribution of CryoValve SG pulmonary human heart valves were $1.7 million and $5.1 ... received FDA clearance for the CryoValve(R) SG pulmonary human heart valve, processed using CryoLife's ...

Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer

... He has more than 20 years of experience in pulmonary research and product development. "Tunde has ... of clinical development programs for pulmonary drugs," said Mark Perry, Aerovance's president ... reviewer and team leader at the Division of pulmonary Drug Products Center for the Drug Evaluation ...

Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant

... studies of 6R-BH4 including proteinuria, pulmonary arterial hypertension and 6R-BH4 plus Vitamin C ... arterial disease, coronary arterial disease and pulmonary hypertension, and has been shown to be a strong ... clinical trials of 6R-BH4 for proteinuria, pulmonary arterial hypertension and other indications, ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... pirfenidone in patients with idiopathic pulmonary fibrosis (IPF). The primary endpoint of ... November 26, 2007. About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately ... has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) ...

Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29

... and fellowship training in both cardiology and pulmonary medicine at Harvard Medical School and the ... in the pathophysiology of chronic obstructive pulmonary disease. For further information regarding ... in the pathophysiology of chronic obstructive pulmonary disease may not be successful, and that our ...

Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury

... and effective medical treatments that mitigate pulmonary injury arising from inhalation of radioactive ... chronic lung disease, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The ... on the development of drug candidates for pulmonary diseases. For more information, please visit ...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

... most feared complication of the disease." pulmonary Hypertension Research titled "Eculizumab Reduces pulmonary Hypertension through Inhibition of ... of patients with PNH (34 of 73) suffered from pulmonary hypertension before starting the trial. In this ...

Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C

... of unblinded data from both trials that serious pulmonary adverse events were higher in the 1200-mcg ... of serious and severe adverse events, including pulmonary adverse events, was also comparable. When we ... The incidence of severe and/or serious pulmonary adverse events was also comparable between these ...

Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411

... to increase airway hydration for the treatment of pulmonary disease. Previously known as P-680, GS9411 is an ... to GS9411 for the treatment of pulmonary diseases, including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and non-CF bronchiectasis. Parion ...

InterMune Reports Third Quarter 2008 Financial Results and Business Highlights

... the first drug approved for idiopathic pulmonary fibrosis (IPF) in any major market in the world. ... pirfenidone as Pirespa(R) in idiopathic pulmonary fibrosis (IPF). -- InterMune confirmed excellent ... a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the ...

CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007

... tissues, the introduction of the CryoValve(R) SG pulmonary human heart valve and, to a lesser extent, price ... Revenues from the distribution of CryoValve SG pulmonary human heart valves were $1.7 million and $3.4 ... FDA clearance for the CryoValve(R) SG pulmonary human heart valve, processed using CryoLife's ...

Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies

... in patients with symptomatic Chronic Obstructive pulmonary Disease (COPD) meet primary endpoints - Data ... showing effects on exacerbation rates and pulmonary function (FEV1). Furthermore, two supporting ... the effect of Daxas on exacerbation rates and pulmonary function (FEV1) in severe and very severe COPD ...

New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence

... patterns of respiration like sleep apnea, and pulmonary complications such as fat emboli syndrome, pulmonary embolus and edema." In addition, researchers also ... (CVP), cardiac index (measured using pulmonary artery catheter), and PVI at three successive ...

InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF

... the treatment of patients with idiopathic pulmonary fibrosis (IPF) in Japan. Pirfenidone was ... the treatment of IPF. About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately ... a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the ...

CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure

... replaced with his or her own pulmonary valve. The pulmonary valve is then replaced with a human cryopreserved pulmonary valve. A new decellurized human pulmonary heart valve, CryoValve(R) SG, processed using ...

Inhaled Treprostinil New Drug Application Filed by FDA

... for inhaled treprostinil for the treatment of pulmonary arterial hypertension. The NDA will be subject to ... company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products. ...

CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007

... tissues, the introduction of the CryoValve(R) SG pulmonary heart valve and, to a lesser extent, price ... Revenues from the distribution of CryoValve SG pulmonary heart valves were $1.4 million and $1.6 million, ... FDA clearance for the CryoValve(R) SG pulmonary human heart valve, processed using CryoLife's ...

U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis

... Survey shows hospital physicians, pulmonary and critical care clinicians, and ... of Hospital Medicine, that show how hospitalists, pulmonary and critical care physicians, and researchers are ... of detection are slow and inaccurate. Of the pulmonary and critical care specialists surveyed, 69 ...

Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

... FRANCISCO, Calif., June 23 /PRNewswire/ -- The pulmonary Hypertension Association (PHA) and ... of the second annual PHA Award of Excellence in pulmonary Arterial Hypertension (PAH) Care. The grant, in ... MD, professor of medicine in the Divisions of pulmonary Sciences and Critical Care Medicine, and ...

Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010

... pursuing new approaches to understand and treat pulmonary fibrosis. "We'd like to express our gratitude ... Schwarz, MD, James C. Campbell Professor of pulmonary Medicine, Division of pulmonary Sciences and Critical Care Medicine University of ...

Pulmo BioTech Announces an Increase in its Stake in PulmoScience

... will dominate the market for the diagnosis of pulmonary Embolism and pulmonary Hypertension, and as such, with the company ... for the diagnosis of Pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ...

ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase

... indicated for the treatment of acute massive pulmonary embolism. ImaRx acquired an approximate four ... for the treatment of acute massive pulmonary embolism. About SonoLysis ImaRx's SonoLysis ... indicated for the treatment of acute massive pulmonary embolism, or blood clots in the lungs. The ...

Pulmo BioTech Announces Appointment of Chief Financial Officer

... for the diagnosis of Pulmonary Embolism, pulmonary Hypertension and Lung Inflammatory diseases under ... to dominate the market for the diagnosis of pulmonary Embolism. In particular, this belief is driven ... based technology for the diagnosis of pulmonary Embolism. In addition, early indications are that ...

eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services

... to provide integrated Cardiac Safety and pulmonary Core Lab Services to clinical researchers ... Cardiopulmonary Exercise Testing, High Definition pulmonary Diagnostics Systems, Spirometry, and Home ... HDpft(TM) systems, the most accurate and precise pulmonary function testing systems worldwide. About eRT ...

CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve

... implantation of the first CryoValve(R) SG pulmonary human heart valve since the product was cleared ... damaged, malformed or malfunctioning native pulmonary valves in pediatric and adult patients. The valve ... defects. In addition, the valve can be used for pulmonary valve replacement during the Ross Procedure, an ...
Other Contents
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... metastasis, yet progress in preventing and treating migratory ... particularly challenging to design drugs that work against ... biology at Harvard Medical School. , "Unfortunately, ... metastasized." , Gujral and colleagues have now identified ... understand how metastasis begins. Their findings may also ...
(Date:11/5/2014)... Kelly Redmond has dedicated his career to understanding ... a general audience. , As deputy director and ... at Nevada,s Desert Research Institute, Redmond has more ... application and dissemination of climate data to the ... Meeting in San Francisco on December 15-19, 2014 ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
(Date:11/24/2014)... Olaparib functions as a chemical of the ... of the first PARP inhibitors. Sufferers with BRCA1/2 strains ... melanoma, and are often immune to other types of ... a exclusive weaknesses, as the tissues of melanoma have ... allow them to proceed splitting. This implies that medication ...
(Date:11/24/2014)... Raymond, Alberta (PRWEB) November 24, 2014 ... of people each day. They break up families, ... there is new hope for those that suffer,” ... “Ground-breaking scientific research is showing that our specialized ... , Hardy will appear on “Mind Over Matter”, ...
(Date:11/24/2014)... 2014 Gersowitz Libo & Korek, P.C., a ... national Tier recognition in the 2015 Edition of U.S. News-Best ... signals a unique combination of quality law practice and breadth ... this honor and especially grateful to our clients whose continued ... ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/23/2014)... (PRWEB) November 24, 2014 iFitDress.com, a well-known ... long black evening gowns . They are now offered ... special offer will last from now to Dec. 15. The ... market. , All the company’s high quality items are ideal ... spending a large sum of money. All its new mint ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank ... an 8 year warranty on its selected hot water tanks. ... due to the impending winter season, it was important for ... service that the company provides. As a result, Pro Ace ... and Bradford hot water tanks. , “Every installer who ...
Breaking Medicine News(10 mins):Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
Other TagsOther Tags